MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-JK-19-0000094
Market Cap
₹463 Cr
PREVEST · BSE
Share Price
₹377.10
-2.31% today
Revenue
₹73.91 Cr
FY 2025-26 · +13.8% YoY
EBITDA
₹25.00 Cr
Margin 33.8%
Net Profit
₹20.48 Cr
FY 2025-26 · +12.8% YoY
P/E (TTM)
21.7x
P/B 3.8x
ROE
17.8%
ROCE 24.2%
Authorised capital
₹12.5 Cr
Registered with MCA
About Prevest Denpro Limited
Data last updated:
Prevest Denpro Limited is a public limited company based in Jammu, Jammu And Kashmir, India. It operates in the dental care and orthodontics segment of the healthcare sector. It was incorporated on 05 May 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN L85199JK1999PLC001969. Its GSTIN is 01AABCP8826B1ZW (Jammu and Kashmir). The company holds 25 GST registrations, of which 3 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 543363.
The company has an authorised share capital of ₹12.5 Cr and a paid-up capital of ₹12 Cr. It is led by directors including Atul Modi (Managing Director) and Namrata Modi (Whole-Time Director).
Its last annual general meeting (AGM) was held on 17 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Epip Kartholi Bari Brahmana Samba, Jammu, Jammu and Kashmir, India – 181133.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹73.91 Cr, a growth of 13.8% compared to the previous year. For the same year it recorded a net profit of ₹20.48 Cr (net margin 27.7%) and EBITDA of ₹25 Cr (EBITDA margin 33.8%). The net worth stands at ₹124.8 Cr (up 18.2% YoY). Total assets are valued at ₹124.8 Cr (up 18.2% YoY).
The company has about 4 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Prevest DenPro. As per MCA filings, the company has open charges of ₹20 Lakh and satisfied charges of ₹2.49 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending. The company has 19 deals on record (13 market trades, 4 secondary share transfers, 1 ipo), with disclosed funding of ₹21.1 Lakh; the latest was in March 2026. Its 4 peer companies in the Healthcare industry (Dental Care), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.) are compared by revenue, 2 larger and 2 smaller; the largest is Ivoclar Vivadent Marketing (India) Private Limited with revenue of ₹106.71 Cr. The company has 10 MSME Form 1 returns on record between 2019 and 2023, listing 248 overdue payments to 27 micro and small suppliers.
Prevest Denpro Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-JK-19-0000094). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website prevestdenpro.com.
Company details
CIN L85199JK1999PLC001969
Registration Number 001969
Incorporation Date 05 May 1999
ROC Jammu
Listing Status Listed - Listed on BSE (543363)
Company Status Active
Date of Last AGM 17 September 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-JK-19-0000094
CIN history
Prevest Denpro has one previous CIN (Corporate Identification Number): U85199JK1999PLC001969. The current CIN is L85199JK1999PLC001969, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85199JK1999PLC001969 | Current |
| U85199JK1999PLC001969 | Previous |
Key People
Atul Modi Managing Director Namrata Modi Whole-Time Director Sai Kalyan Surapaneni Director Recognitions & Rankings of Prevest Denpro
Contact details
Prevest Denpro Limited's registered office is in Jammu, Jammu & Kashmir. Its website is prevestdenpro.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressEpip Kartholi Bari Brahmana Samba, Jammu, Jammu and Kashmir, India – 181133
- IndustryHealthcare, Dental Care & Orthodontics
To see the full contact details of Prevest Denpro Limited, buy the company report.
Comprehensive company report
Prevest Denpro Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Prevest Denpro operates one associated brand: Prevest DenPro. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Dental materials manufacturer | prevestdenpro.com |
Business activity
The main business activity of Prevest Denpro is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Prevest Denpro Limited, buy the company report.
Financials of Prevest Denpro Limited
FY 2025-26 filings availablePrevest Denpro Limited reported revenue of ₹73.91 Cr (up 13.8% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue
₹73.91 Cr
+13.8% YoY
EBITDA
₹25.00 Cr
+11.9% YoY
Profit After Tax
₹20.48 Cr
+12.8% YoY
Net Worth
₹125 Cr
+18.2% YoY
Total Assets
₹125 Cr
+18.2% YoY
Total Debt
Nil
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Income statement | |||
| Revenue | 73.91 | 64.95 | 58.50 |
| Revenue growth | +13.8% | +11.0% | - |
| EBITDA | 25.00 | 22.34 | 20.05 |
| EBITDA margin | +33.8% | +34.4% | +34.3% |
| Profit before tax | 27.61 | 24.25 | 21.42 |
| Net profit | 20.48 | 18.15 | 16.12 |
| Net profit margin | +27.7% | +27.9% | +27.6% |
| EPS (₹) | 17.07 | 15.13 | 13.44 |
| Balance sheet | |||
| Total assets | 125 | 106 | 88.62 |
| Net worth | 125 | 106 | 88.61 |
| Total debt | 0.00 | 0.00 | 0.00 |
| Cash & bank | 72.85 | 60.90 | 48.61 |
| Net working capital | 90.64 | 75.06 | 60.90 |
| Cash flow | |||
| Cash from operations | 14.81 | 14.82 | 11.62 |
| Cash from investing | (1.65) | (1.33) | (1.70) |
| Cash from financing | (1.20) | (1.20) | (0.32) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.07 | 18.94 | 18.46 | 18.64 | 15.77 | 18.45 | 14.95 | 16.27 |
| Revenue growth (YoY) | +20.9% | +2.7% | +23.5% | +14.6% | +18.0% | - | - | - |
| Other income | 1.32 | 1.41 | 1.15 | 1.19 | 1.17 | 1.08 | 1.09 | 1.04 |
| EBITDA | 6.77 | 6.91 | 5.80 | 6.68 | 5.32 | 6.54 | 5.21 | 5.81 |
| EBITDA margin | +35.5% | +36.5% | +31.4% | +35.8% | +33.7% | +35.4% | +34.8% | +35.7% |
| Depreciation | 0.52 | 0.51 | 0.51 | 0.50 | 0.49 | 0.47 | 0.48 | 0.47 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 7.57 | 7.81 | 6.44 | 7.37 | 6.00 | 7.15 | 5.82 | 6.38 |
| Tax | 1.92 | 1.99 | 1.72 | 1.83 | 1.58 | 2.01 | 1.29 | 1.57 |
| Net profit | 5.65 | 5.82 | 4.72 | 5.54 | 4.42 | 5.14 | 4.53 | 4.81 |
| EPS (₹) | 4.70 | 4.85 | 3.93 | 4.62 | 3.67 | 4.28 | 3.77 | 4.01 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 73.58 | 64.99 | 58.51 | 50.75 | 39.37 | 29.01 | 23.26 |
| Revenue growth | +13.2% | +11.1% | +15.3% | +28.9% | +35.7% | +24.7% | - |
| EBITDA | 25.80 | 22.33 | 20.04 | 19.80 | 15.23 | 9.02 | 5.18 |
| EBITDA margin | +35.1% | +34.4% | +34.3% | +39.0% | +38.7% | +31.1% | +22.3% |
| Profit before tax | 28.54 | 24.29 | 21.41 | 20.94 | 16.06 | 9.34 | 6.27 |
| Net profit | 21.41 | 18.22 | 16.11 | 15.70 | 11.57 | 7.21 | 4.99 |
| Net profit margin | +29.1% | +28.0% | +27.5% | +30.9% | +29.4% | +24.9% | +21.5% |
| EPS (₹) | 17.84 | 15.16 | 13.43 | 13.09 | 9.64 | 252.87 | 175.74 |
| Balance sheet | |||||||
| Total assets | 126 | 106 | 88.60 | 72.80 | 58.45 | 23.89 | 17.10 |
| Net worth | 126 | 106 | 88.60 | 72.79 | 57.08 | 22.50 | 15.31 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 1.37 | 1.39 | 1.64 |
| Cash & bank | 72.65 | 60.46 | 48.43 | 39.00 | 42.32 | 16.42 | 10.30 |
| Net working capital | 90.19 | 74.50 | 60.84 | 47.68 | 46.57 | 16.62 | 11.58 |
| Cash flow | |||||||
| Cash from operations | 15.86 | 14.98 | 11.49 | 10.43 | 6.96 | 8.76 | 4.73 |
| Cash from investing | (2.47) | (1.74) | (1.75) | (12.38) | (3.87) | (1.93) | (0.52) |
| Cash from financing | (1.20) | (1.20) | (0.32) | (1.37) | 22.82 | (0.57) | 0.03 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.44 | 18.90 | 18.37 | 18.66 | 15.72 | 18.54 | 14.93 | 16.26 |
| Revenue growth (YoY) | +23.7% | +1.9% | +23.0% | +14.8% | +17.8% | - | - | - |
| Other income | 1.33 | 1.46 | 1.16 | 1.20 | 1.17 | 1.08 | 1.10 | 1.07 |
| Total expenses | 12.56 | 11.82 | 12.16 | 11.96 | 10.19 | 11.92 | 9.79 | 10.44 |
| EBITDA | 6.88 | 7.08 | 6.21 | 6.70 | 5.53 | 6.62 | 5.14 | 5.82 |
| EBITDA margin | +35.4% | +37.5% | +33.8% | +35.9% | +35.2% | +35.7% | +34.4% | +35.8% |
| Depreciation | 0.52 | 0.50 | 0.51 | 0.50 | 0.49 | 0.47 | 0.48 | 0.47 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 7.69 | 8.04 | 6.86 | 7.40 | 6.21 | 7.23 | 5.76 | 6.42 |
| Tax | 1.92 | 1.99 | 1.72 | 1.83 | 1.58 | 1.99 | 1.29 | 1.57 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 24 Oct 2026
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.07 | 18.94 | 18.46 | 18.64 | 15.77 | 18.45 | 14.95 | 16.27 |
| Revenue growth (YoY) | +20.9% | +2.7% | +23.5% | +14.6% | +18.0% | - | - | - |
| Other income | 1.32 | 1.41 | 1.15 | 1.19 | 1.17 | 1.08 | 1.09 | 1.04 |
| EBITDA | 6.77 | 6.91 | 5.80 | 6.68 | 5.32 | 6.54 | 5.21 | 5.81 |
| EBITDA margin | +35.5% | +36.5% | +31.4% | +35.8% | +33.7% | +35.4% | +34.8% | +35.7% |
| Depreciation | 0.52 | 0.51 | 0.51 | 0.50 | 0.49 | 0.47 | 0.48 | 0.47 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 7.57 | 7.81 | 6.44 | 7.37 | 6.00 | 7.15 | 5.82 | 6.38 |
| Tax | 1.92 | 1.99 | 1.72 | 1.83 | 1.58 | 2.01 | 1.29 | 1.57 |
| Net profit | 5.65 | 5.82 | 4.72 | 5.54 | 4.42 | 5.14 | 4.53 | 4.81 |
| EPS (₹) | 4.70 | 4.85 | 3.93 | 4.62 | 3.67 | 4.28 | 3.77 | 4.01 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Revenue | 73.91 | 64.95 | 58.50 |
| Revenue growth | +13.8% | +11.0% | - |
| Other income | 4.92 | 4.07 | 2.86 |
| Total expenses | 48.91 | 42.61 | 38.45 |
| Employee cost | 8.65 | 7.26 | 5.92 |
| EBITDA | 25.00 | 22.34 | 20.05 |
| EBITDA margin | +33.8% | +34.4% | +34.3% |
| Depreciation | 2.03 | 1.90 | 1.28 |
| Interest | 0.28 | 0.26 | 0.21 |
| Profit before tax | 27.61 | 24.25 | 21.42 |
| Tax | 7.13 | 6.10 | 5.30 |
| Net profit | 20.48 | 18.15 | 16.12 |
| Net profit margin | +27.7% | +27.9% | +27.6% |
| EPS (₹) | 17.07 | 15.13 | 13.44 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Equity & liabilities | |||
| Share capital | 12.00 | 12.00 | 12.00 |
| Reserves & surplus | 113 | 93.57 | 76.61 |
| Shareholders' funds (net worth) | 125 | 106 | 88.61 |
| Minority interest | 0.00 | 0.00 | 0.00 |
| Secured loans | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 0.00 | 0.00 | 0.00 |
| Total debt | 0.00 | 0.00 | 0.00 |
| Total liabilities | 125 | 106 | 88.62 |
| Assets | |||
| Gross block | 36.58 | 34.68 | 32.72 |
| Net block | 26.70 | 26.81 | 26.75 |
| Capital work in progress | 0.00 | 0.00 | 0.00 |
| Investments | 8.69 | 4.70 | 1.66 |
| Inventories | 10.89 | 8.04 | 6.24 |
| Sundry debtors | 8.71 | 7.67 | 8.13 |
| Cash & bank balances | 72.85 | 60.90 | 48.61 |
| Loans & advances | 5.34 | 4.41 | 3.43 |
| Total current assets | 97.79 | 81.02 | 66.41 |
| Total current liabilities | 7.15 | 5.96 | 5.51 |
| Net working capital | 90.64 | 75.06 | 60.90 |
| Total assets | 125 | 106 | 88.62 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Opening cash | 60.90 | 48.61 | 39.00 |
| Net cash from operating activities | 14.81 | 14.82 | 11.62 |
| Net cash from investing activities | (1.65) | (1.33) | (1.70) |
| Net cash from financing activities | (1.20) | (1.20) | (0.32) |
| Net change in cash | 11.96 | 12.29 | 9.61 |
| Closing cash | 72.85 | 60.90 | 48.61 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Growth | |||
| Sales growth | +13.8% | +11.0% | - |
| EBITDA growth | +11.9% | +11.4% | - |
| PBT growth | +13.9% | +13.2% | +9997.0% |
| Net income growth | +12.8% | +12.6% | - |
| Profitability & leverage | |||
| Net income margin | +27.7% | +27.9% | +27.6% |
| Return on capital employed | +24.2% | +25.2% | +24.4% |
| Return on net worth | +17.8% | +18.7% | +18.2% |
| Debt / equity | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 |
| Interest cover | 1.22 | 1.27 | 1.12 |
| Efficiency & per share | |||
| Fixed asset turnover | 2.07 | 1.93 | 1.79 |
| Inventory turnover | 7.81 | 9.10 | 9.38 |
| Debtors turnover | 9.02 | 8.22 | 7.20 |
| EPS (₹) | 17.07 | 15.13 | 13.44 |
| Dividend per share (₹) | 0.00 | 1.00 | 1.00 |
| Book value per share (₹) | 103.97 | 87.95 | 73.83 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.44 | 18.90 | 18.37 | 18.66 | 15.72 | 18.54 | 14.93 | 16.26 |
| Revenue growth (YoY) | +23.7% | +1.9% | +23.0% | +14.8% | +17.8% | - | - | - |
| Other income | 1.33 | 1.46 | 1.16 | 1.20 | 1.17 | 1.08 | 1.10 | 1.07 |
| Total expenses | 12.56 | 11.82 | 12.16 | 11.96 | 10.19 | 11.92 | 9.79 | 10.44 |
| EBITDA | 6.88 | 7.08 | 6.21 | 6.70 | 5.53 | 6.62 | 5.14 | 5.82 |
| EBITDA margin | +35.4% | +37.5% | +33.8% | +35.9% | +35.2% | +35.7% | +34.4% | +35.8% |
| Depreciation | 0.52 | 0.50 | 0.51 | 0.50 | 0.49 | 0.47 | 0.48 | 0.47 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 7.69 | 8.04 | 6.86 | 7.40 | 6.21 | 7.23 | 5.76 | 6.42 |
| Tax | 1.92 | 1.99 | 1.72 | 1.83 | 1.58 | 1.99 | 1.29 | 1.57 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 73.58 | 64.99 | 58.51 | 50.75 | 39.37 | 29.01 | 23.26 |
| Revenue growth | +13.2% | +11.1% | +15.3% | +28.9% | +35.7% | +24.7% | - |
| Other income | 5.00 | 4.11 | 2.86 | 2.03 | 1.62 | 1.04 | 1.79 |
| Total expenses | 47.78 | 42.66 | 38.47 | 30.95 | 24.14 | 19.99 | 18.08 |
| Employee cost | 7.22 | 6.17 | 5.58 | 5.46 | 4.07 | 3.38 | 4.51 |
| EBITDA | 25.80 | 22.33 | 20.04 | 19.80 | 15.23 | 9.02 | 5.18 |
| EBITDA margin | +35.1% | +34.4% | +34.3% | +39.0% | +38.7% | +31.1% | +22.3% |
| Depreciation | 1.99 | 1.90 | 1.28 | 0.68 | 0.52 | 0.47 | 0.44 |
| Interest | 0.27 | 0.25 | 0.21 | 0.21 | 0.27 | 0.25 | 0.26 |
| Profit before tax | 28.54 | 24.29 | 21.41 | 20.94 | 16.06 | 9.34 | 6.27 |
| Tax | 7.13 | 6.07 | 5.30 | 5.24 | 4.48 | 2.13 | 1.27 |
| Net profit | 21.41 | 18.22 | 16.11 | 15.70 | 11.57 | 7.21 | 4.99 |
| Net profit margin | +29.1% | +28.0% | +27.5% | +30.9% | +29.4% | +24.9% | +21.5% |
| EPS (₹) | 17.84 | 15.16 | 13.43 | 13.09 | 9.64 | 252.87 | 175.74 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 0.29 | 0.29 |
| Reserves & surplus | 114 | 93.60 | 76.60 | 60.79 | 45.08 | 22.21 | 15.02 |
| Shareholders' funds (net worth) | 126 | 106 | 88.60 | 72.79 | 57.08 | 22.50 | 15.31 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 1.37 | 1.39 | 1.56 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 1.37 | 1.39 | 1.64 |
| Total liabilities | 126 | 106 | 88.60 | 72.80 | 58.45 | 23.89 | 17.10 |
| Assets | |||||||
| Gross block | 36.44 | 34.67 | 32.72 | 12.10 | 10.84 | 8.96 | 8.33 |
| Net block | 26.58 | 26.80 | 26.75 | 7.41 | 6.72 | 5.36 | 5.21 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 16.89 | 4.72 | 1.71 | 0.11 |
| Investments | 9.17 | 5.18 | 1.71 | 1.19 | 0.73 | 0.44 | 0.23 |
| Inventories | 10.73 | 7.89 | 6.22 | 4.79 | 3.26 | 1.27 | 1.13 |
| Sundry debtors | 8.79 | 7.81 | 8.17 | 4.30 | 2.32 | 3.75 | 2.16 |
| Cash & bank balances | 72.65 | 60.46 | 48.43 | 39.00 | 42.32 | 16.42 | 10.30 |
| Loans & advances | 5.20 | 4.41 | 3.54 | 5.03 | 4.07 | 1.72 | 1.76 |
| Total current assets | 97.37 | 80.57 | 66.36 | 53.12 | 51.97 | 23.16 | 15.35 |
| Total current liabilities | 7.18 | 6.07 | 5.52 | 5.44 | 5.40 | 6.54 | 3.77 |
| Net working capital | 90.19 | 74.50 | 60.84 | 47.68 | 46.57 | 16.62 | 11.58 |
| Total assets | 126 | 106 | 88.60 | 72.80 | 58.45 | 23.89 | 17.10 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 60.46 | 48.43 | 39.00 | 42.32 | 16.42 | 10.16 | 6.06 |
| Net cash from operating activities | 15.86 | 14.98 | 11.49 | 10.43 | 6.96 | 8.76 | 4.73 |
| Net cash from investing activities | (2.47) | (1.74) | (1.75) | (12.38) | (3.87) | (1.93) | (0.52) |
| Net cash from financing activities | (1.20) | (1.20) | (0.32) | (1.37) | 22.82 | (0.57) | 0.03 |
| Net change in cash | 12.19 | 12.04 | 9.42 | (3.32) | 25.91 | 6.26 | 4.24 |
| Closing cash | 72.65 | 60.46 | 48.43 | 39.00 | 42.32 | 16.42 | 10.30 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +13.2% | +11.1% | +15.3% | +28.9% | +35.7% | +24.7% | - |
| EBITDA growth | +15.5% | +11.4% | +1.2% | +30.0% | +68.9% | +74.1% | - |
| PBT growth | +17.5% | +13.5% | +2.2% | +30.4% | +72.0% | +49.0% | +67.7% |
| Net income growth | +17.5% | +13.1% | +2.6% | +35.7% | +60.5% | +44.5% | - |
| Revenue CAGR (3Y) | +13.2% | +18.2% | +26.4% | +29.7% | +25.5% | - | - |
| EBITDA CAGR (3Y) | +9.2% | +13.6% | +30.5% | +56.4% | +58.0% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +29.1% | +28.0% | +27.5% | +30.9% | +29.4% | +24.9% | +21.5% |
| Return on capital employed | +24.9% | +25.3% | +26.8% | +32.3% | +39.6% | +46.8% | +45.2% |
| Return on net worth | +18.5% | +18.7% | +20.0% | +24.2% | +29.1% | +38.1% | +39.1% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.08 | 0.12 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.08 | 0.12 |
| Interest cover | 1.13 | 1.22 | 1.12 | 1.10 | 1.84 | 2.92 | 5.49 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.07 | 1.93 | 2.61 | 4.42 | 3.98 | 3.36 | 2.89 |
| Inventory turnover | 7.90 | 9.21 | 10.63 | 12.61 | 17.38 | 24.18 | 28.54 |
| Debtors turnover | 8.87 | 8.13 | 9.38 | 15.33 | 12.97 | 9.82 | 10.09 |
| EPS (₹) | 17.84 | 15.16 | 13.43 | 13.09 | 9.64 | 252.87 | 175.74 |
| Dividend per share (₹) | 0.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 104.83 | 87.98 | 73.82 | 60.65 | 47.56 | 789.33 | 537.05 |
To see the full year-wise statements and ratios of Prevest Denpro Limited, buy the company report.
Board of directors of Prevest Denpro Limited
Prevest Denpro has 8 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Modi Also directs: Denvisio Biomed Limited | Managing Director | 05 May 1999 | 27 Years 5 Months | Current |
| Sai Kalyan Surapaneni Also directs: Denvisio Biomed Limited | Director | 21 Dec 2020 | 5 Years 10 Months | Current |
| Namrata Modi Also directs: Denvisio Biomed Limited | Whole-Time Director | 05 May 1999 | 27 Years 5 Months | Current |
| Niharika Modi Also directs: Denvisio Biomed Limited | Director | 10 Dec 2020 | 5 Years 10 Months | Current |
| Vaibhav Munjal Also directs: Denvisio Biomed Limited | Director | 27 Apr 2023 | 3 Years 5 Months | Current |
| Piyush Kiranprakash Gupta | Director | 22 Apr 2026 | 0 Years 6 Months | Current |
Showing 6 of 8 current directors. View all directors
Peer comparison
Prevest Denpro Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Dental Care), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ivoclar Vivadent Marketing (India) Private Limited | ₹106.71 Cr (FY 2025) | 3.0% | Gurugram, Haryana, India | |||
| S J Healthcare Private Limited | ₹85.52 Cr (FY 2025) | 15.0% | Mumbai, Maharashtra, India | |||
| Prevest Denpro Limitedthis company | ₹73.91 Cr (FY 2026) | ₹20.48 Cr | 27.7% | 13.8% | Jammu, Jammu And Kashmir, India | |
| Total Dental Care Private Limited | ₹55.09 Cr (FY 2024) | 14.0% | Mumbai, Maharashtra, India | |||
| Partha Dental Care India Private Limited | ₹50.68 Cr (FY 2025) | -8.0% | Tirupati, Andhra Pradesh, India |
To see the full peer comparison of Prevest Denpro Limited, buy the company report.
Auditor
Prevest Denpro Limited is audited by Mittal & Associates for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mittal & Associates | FY 2025 | 106456W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 73.60%, foreign institutional investors hold 0.60%, domestic institutional investors hold 0.80% and retail and other public shareholders hold 25.00%.
Sep 2026
QUARTER
73.60% Promoters
0.80% DII (Domestic Institutional)
0.60% FII (Foreign Institutional)
25.00% Retail & Others
Promoter holding - history
Now 73.60% · Sep 2026High 73.60% · Dec 2025Low 73.60% · Dec 2025
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 73.60% | 73.60% | 73.60% | 73.60% |
| Public | 26.40% | 26.40% | 26.40% | 26.40% |
Charges & borrowings
Open charges
₹20 Lakh
Satisfied charges
₹2.49 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Mar 2005 | 90323919 | Punjab National Bank | ₹20 Lakh | Open | |
| 05 Jan 2015 | 10545917 | Punjab National Bank | ₹5 Lakh | Satisfied | |
| 31 Jul 2014 | 10523984 | Punjab National Bank | ₹48 Lakh | Satisfied | |
| 29 May 2014 | 10523887 | Punjab National Bank | ₹14.98 Lakh | Satisfied | |
| 19 May 2014 | 10523502 | Punjab National Bank | ₹7.15 Lakh | Satisfied |
To see the full charge records of Prevest Denpro Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Prevest Denpro Limited has 19 deals on record (13 market trades, 4 secondary share transfers, 1 ipo), with disclosed funding of ₹21.1 Lakh; the latest was in March 2026.
Total deals
19
Market trades
13
Secondary share transfers
4
IPO
1
Funding round
1
Disclosed funding
₹21.1 Lakh
Deals on record (5 of 19)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2021 | Market trade | ₹1.73 Cr | Buyer: Alpha Leon Enterprises LLP Seller: Alpha Leon Enterprises LLP |
| Oct 2021 | Market trade | ₹19.67 Cr | Buyer: Maruti Nandan Colonizers Private Limited, Alpha Leon Enterprises LLP , Mansi Share and Stock Broking Private Limited Seller: Alpha Leon Enterprises LLP , Mansi Share and Stock Broking Private Limited |
| Sep 2021 | Market trade | ₹7.83 Cr | Buyer: Mansi Share and Stock Broking Private Limited , Prudent Ventures Seller: Resonance Opportunities Fund |
| Sep 2021 | Market trade | ₹8 Cr | Buyer: Alpha Leon Enterprises LLP Seller: Moneyywise Financial Services Pvt Ltd |
| Sep 2021 | IPO | ₹26.61 Cr | Investors: IPO - Prevest Denpro Limited, Next Orbit Ventures, Maven India Fund |
To see the full deal history of Prevest Denpro Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Prevest Denpro Limited has 2 court cases on record: 2 filed by Prevest Denpro. 1 case is pending and 1 is disposed.
Total cases
2
Filed by the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jammu, Jammu and Kashmir | Court case (SUIT FOR DAMAGES) | Filed by the company against an individual | Pending |
| District court, Jammu, Jammu and Kashmir | Court case (Permanent P I(Civil)) | Filed by the company against an individual | Disposed |
To see the full case history of Prevest Denpro Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Prevest Denpro Limited has 10 MSME Form 1 returns on record between 2019 and 2023, listing 248 overdue payments to 27 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 27)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Sahyogg Packers | |||
| an individual supplier | |||
| Stallion Packaging Private Limited | |||
| Shri Ram Sons Wax Private Limited |
To see the full MSME payment records of Prevest Denpro Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Prevest Denpro has 1 subsidiary company. This group structure data is as of FY 2025. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Denvisio Biomed Limited | U32509HR2023PLC111676 |
To see the full group structure of Prevest Denpro Limited, buy the company report.
GST
Prevest Denpro has 25 GST registrations: 3 active and 22 cancelled or inactive.
Total GSTINs
25
Active
3
Cancelled / inactive
22
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01AABCP8826B1ZW | Jammu and Kashmir | Active | 08 Jul 2017 |
| 01AABCP8826B2ZV | Jammu and Kashmir | Active | 08 Jul 2017 |
| 06AABCP8826B1ZM | Haryana | Active | 09 Jul 2020 |
To see the full GST registrations and return filing status of Prevest Denpro Limited, buy the company report.
Recent activity
Prevest Denpro Limited has 15 board changes on record since 1999: 13 appointments and 2 cessations. The latest: Sukhen Pal Babuta was appointed as Director on 27 May 2026.
AGM
Prevest Denpro Limited last Annual general meeting of members was held on 17 Sep 2026 as per latest MCA records.
Appointed
Sukhen Pal Babuta was appointed as Director.
Appointed
Abhijeet Sadashiv Haridas was appointed as Director.
Appointed
Piyush Kiranprakash Gupta was appointed as Director.
Filing
Prevest Denpro Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Jammu.
Appointed
Pardeep Gandotra was appointed as Director.
Appointed
Vaibhav Munjal was appointed as Director.
Appointed
Nikhil Shrikant Bobade was appointed as Director.
Appointed
Sudeep Murthy was appointed as Director.
Charges
A charge registered on 08 Dec 2010 via Charge ID 10258300 with Punjab National Bank was fully satisfied on 16 Feb 2021.
Charges
A charge registered on 11 Dec 2008 via Charge ID 10135345 with Punjab National Bank was fully satisfied on 16 Feb 2021.
Charges
A charge registered on 18 Oct 2000 via Charge ID 90323796 with Punjab National Bank was fully satisfied on 16 Feb 2021.
36 earlier events are in the company report.
News
Frequently asked questions
Prevest Denpro is an active public limited company based in Jammu, Jammu And Kashmir, India. The company works in dental care and orthodontics, within the healthcare industry. It was incorporated on 05 May 1999 (27+ years old) and is registered under CIN L85199JK1999PLC001969. Listed on BSE: 543363.
Prevest Denpro reported revenue of ₹73.91 Cr for FY 2025-26 (up 13.8% YoY) based on consolidated financials.
Prevest Denpro has 8 current directors:
- Atul Modi - Managing Director
- Namrata Modi - Whole-Time Director
- Sai Kalyan Surapaneni - Director
- Niharika Modi - Director
- Vaibhav Munjal - Director
- Piyush Kiranprakash Gupta - Director
- Abhijeet Sadashiv Haridas - Director
- Sukhen Pal Babuta - Director
The latest financial statements of Prevest Denpro on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 17 September 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Prevest Denpro is 01AABCP8826B1ZW, registered in Jammu and Kashmir. The company has 25 GST registrations in all, of which 3 are active and 22 are cancelled or inactive. Other active GSTINs include 01AABCP8826B2ZV (Jammu and Kashmir), 06AABCP8826B1ZM (Haryana).
The CIN (Corporate Identification Number) of Prevest Denpro is L85199JK1999PLC001969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Prevest Denpro is a listed company as per MCA records. Its shares are listed on BSE (code: 543363).
Prevest Denpro has 2 court cases on record: 2 filed by the company. 1 is pending.
Prevest Denpro was incorporated on 05 May 1999, making it 27+ years old. It is registered with the Registrar of Companies, Jammu.
Prevest Denpro has 19 deals on record (13 market trades, 4 secondary share transfers, 1 ipo), with disclosed funding of ₹21.1 Lakh; the latest was in March 2026.
The peers of Prevest Denpro by revenue are Ivoclar Vivadent Marketing (India) Private Limited, S J Healthcare Private Limited, Total Dental Care Private Limited, Partha Dental Care India Private Limited, all in the Healthcare industry (Dental Care), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.).
Sukhen Pal Babuta was appointed as Director on 27 May 2026. Abhijeet Sadashiv Haridas was appointed as Director on 22 Apr 2026. Piyush Kiranprakash Gupta was appointed as Director on 22 Apr 2026. Prevest Denpro has 15 board changes on record in total.